Insulin dependent diabetes (IDD) affects an estimated 1 in 300 persons in the U.S. Despite advances in management, most patients still develop life threatening macro and microvascular complications. No imminent therapeutic breakthroughs appear close to altering this situation anytime soon. An approach that attempts to delay the onset of IDD has therefore become increasingly attractive. IDD probably results from a chronic autoimmune ablation of pancreatic beta cells occurring over a time frame of years in most patients. Early reports of trails of non specific immunosuppressive therapy if given soon after diagnosis have suggested that the disease can be arrested however for most patients, this is too late, and the side effects too significant to contemplate indefinite continuance in those who do respond. Intervention must be earlier and more specific. This program project with 7 individual studies and 4 cores involving basic science and clinical investigators will examine the genetic susceptibility and pathogenic events in IDD in both man and non obese diabetic (NOD) mouse. One project will pursue the molecular genetics of HLA-D genes in human IDD, another the genetics of the class II MHC, T cell antigens, T cell receptors, and exon polymorphisms 5"""""""" to the insulin gene in NOD mice. New early disease markers will be sought by developing human and mouse insulinomas to identify beta cell surface reactive autoantibodies. Ways of identifying chronic lymphocyte activation to detect latent human IDD, will be explored using flow cytometry analyses and techniques of cellular immunology. Psychological stress as an inducer of human IDD will be evaluated. Extra pancreatic sites of insulin production will be examined in rodents, and the effects of diabetes on these processes will be studied in NOD mice. Redox perturbations and superoxide radical generation as a possible common ultimate pathway for beta cell necrosis will be studied in NOD mice and therapeutic manipulations to affect diabetic outcomes attempted.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK039079-04
Application #
3095523
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1987-08-01
Project End
1992-07-31
Budget Start
1990-08-01
Budget End
1991-07-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Hood, Korey K; Johnson, Suzanne Bennett; Baughcum, Amy E et al. (2006) Maternal understanding of infant diabetes risk: differential effects of maternal anxiety and depression. Genet Med 8:665-70
Hood, Korey K; Bennett Johnson, Suzanne; Carmichael, Stacy K et al. (2005) Depressive symptoms in mothers of infants identified as genetically at risk for type 1 diabetes. Diabetes Care 28:1898-903
Baughcum, Amy E; Johnson, Suzanne Bennett; Carmichael, Stacy K et al. (2005) Maternal efforts to prevent type 1 diabetes in at-risk children. Diabetes Care 28:916-21
Bennett Johnson, Suzanne; Baughcum, Amy E; Carmichael, Stacy K et al. (2004) Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care 27:392-7
Carmichael, Stacy K; Johnson, Suzanne Bennett; Baughcum, Amy et al. (2003) Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet Med 5:77-83
Johnson, S B (2001) Screening programs to identify children at risk for diabetes mellitus: psychological impact on children and parents. J Pediatr Endocrinol Metab 14 Suppl 1:653-9
Lu, C C; Ye, Y; She, J X et al. (1996) Evolutionary origins of retroposon lineages of Mhc class II Ab alleles. Immunogenetics 43:115-24
Lan, M S; Wasserfall, C; Maclaren, N K et al. (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 93:6367-70
Bennett Johnson, S; Tercyak Jr, K P (1995) Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 18:1370-2
Cantor, A B; Krischer, J P; Cuthbertson, D D et al. (1995) Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. J Clin Endocrinol Metab 80:3739-43

Showing the most recent 10 out of 41 publications